Devyser Diagnostics AB has entered an in vitro diagnostic development agreement with Illumina, Inc. (Nasdaq: ILMN). The agreement enables Devyser to develop and offer its in vitro diagnostic (IVD) tests on Illumina MiSeqDx next-generation sequencing (NGS) instrument in the United States and Europe. The IVD development agreement allows Devyser to perform regulatory registrations of its […]

MENLO PARK, Calif. – Deepcell, a pioneer in artificial intelligence (AI)-powered single cell analysis to fuel deep biological discoveries, today announced a research collaboration with NVIDIA to accelerate the development and adoption of advanced computer vision solutions in life sciences. Deepcell, which already uses the NVIDIA A4000 and NVIDIA AI technology, will incorporate NVIDIA AI into its […]

Marlborough, MA – Scitara, a market-leading innovator in laboratory digital transformation, has announced an agreement with Waters Corporation (NYSE: WAT), a global leader in analytical instruments and software. Under the agreement, Waters has licensed Scitara’s Digital Lab Exchange DLX™ cloud platform to communicate with Waters’ Empower™ Chromatography Data System and waters_connect™ Lab Informatics Platform to […]

Boston, MA and Rolle, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced a collaboration with Exactis Innovation, based in Montreal, Quebec, who will contribute to cancer research and data-driven decision-making through SOPHiA GENETICS’ multimodal real-world data offering. Exactis Innovation is a non-profit network of hospital partners across Canada dedicated […]

Teledyne LABS is now a major distributor of Ecodyst evaporation systems used in laboratories worldwide. Ecodyst uses proprietary technology for the efficient and gentle re​moval of solvent from samples in numerous advanced scientific processes. Principle users of Teledyne LABS chromatography instruments and Ecodyst benchtop rotary evaporator (rotavap) and large-scale evaporation systems include the pharmaceutical and […]

The Thermo Fisher Scientific ViewRNA technology combined with Akoya’s market leading spatial biology solutions will enable rapid, whole-slide imaging of RNA and protein biomarkers MARLBOROUGH, Mass.– Akoya Biosciences, Inc., (NASDAQ: AKYA), The Spatial Biology Company®, today announced that it has entered into a license and distribution agreement with Thermo Fisher Scientific, Inc. The agreement enables […]

SAN DIEGO — Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced it has signed an agreement with Janssen Research & Development, LLC (Janssen). This collaboration will be the first relating to the development of Illumina’s novel molecular residual disease (MRD) assay, a whole-genome sequencing (WGS) multi-cancer research solution that […]

AGD delivered ~86,000 whole genomes in 2023, including a unique diverse ancestry cohort Expanded pharma engagement enhances AGD’s ability to develop multiomic datasets SAN DIEGO — Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, in collaboration with Nashville Biosciences, LLC (NashBio), a leading clinical and genomic data company and wholly owned subsidiary […]

Shimadzu Corporation has signed a joint program agreement with Kobe University for the purpose of developing the field of atmospheric studies, which originated at Kobe University, and training human resources for leadership within global society. To date, both parties have implemented a number of collaborative research projects, and in the future, we will engage in […]

WATERTOWN, Mass. — Fluent BioSciences, a leader in breakthrough single-cell analysis technology, and Element Biosciences, a pioneer in novel sequencing solutions, are excited to announce their collaboration to enhance the accessibility and scalability of single-cell RNA sequencing (scRNA-seq). Single-cell RNA sequencing has been a crucial tool in unraveling cellular and molecular diversity within complex tissues. […]